Tenax Therapeutics (TENX) Short-Term Debt repayments (2011 - 2015)
Tenax Therapeutics (TENX) reported Short-Term Debt repayments of $172025.0 for Q1 2015, up 103.62% on a YoY basis from $84483.9 in Q1 2014, and up 103.62% sequentially from -$4.8 million in Q1 2014.
Tenax Therapeutics (TENX) Short-Term Debt repayments (2011 - 2015) Analysis & Trends
Tenax Therapeutics (TENX) has 5 years of Short-Term Debt repayments data on file, last reported at $172025.0 in Q1 2015.
- For the quarter ending Q1 2015, Short-Term Debt repayments rose 103.62% year-over-year to $172025.0; the trailing twelve-month figure through Dec 2015 stood at $172025.0 (changed N/A YoY), and the FY2015 full-year result was $172025.0, up 21.73% from the prior year.
- Short-Term Debt repayments advanced to $172025.0 in Q1 2015, from -$4.8 million in the prior quarter.
- In the past five years, Short-Term Debt repayments ranged from a high of $4.9 million in Q3 2013 to a low of -$4.8 million in Q1 2014.
- A 5-year average of $627045.4 and a median of $172025.0 in 2015 frame the typical range for Short-Term Debt repayments.
- Across the five-year window, Short-Term Debt repayments sank 4730.2% in 2014 and jumped 103.62% in 2015, its largest moves.
- Tracing TENX's Short-Term Debt repayments over 5 years: stood at $700000.0 in 2011, then sank by 80.33% to $137692.0 in 2012, then tumbled by 118.15% to -$24995.0 in 2013, then slumped by 18919.28% to -$4.8 million in 2014, then soared by 103.62% to $172025.0 in 2015.
- Business Quant data shows TENX's Short-Term Debt repayments at $172025.0 in Q1 2015, -$4.8 million in Q1 2014, and -$24995.0 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2015 | 172,025.00 |
| Jan 31, 2015 | 172,025.00 |
| Jan 31, 2014 | -4.75 Mn |
| Jan 31, 2014 | -4.75 Mn |
| Oct 31, 2013 | -24,995.00 |
| Oct 31, 2013 | -24,995.00 |
| Jul 31, 2013 | 4.92 Mn |
| Jul 31, 2013 | 4.92 Mn |
| Jan 31, 2013 | 102,671.00 |
| Jan 31, 2013 | 102,671.00 |
| Jan 31, 2012 | 137,692.00 |
| Jan 31, 2012 | 137,692.00 |
| Jul 31, 2011 | 700,000.00 |
| Jul 31, 2011 | 700,000.00 |
| Apr 30, 2011 | 2.30 Mn |
| Apr 30, 2011 | 2.30 Mn |
| Jan 31, 2011 | 2.09 Mn |
| Jan 31, 2011 | 2.09 Mn |